Magnetic nanoparticles (MNPs) treated with phosphoric acid were used to improve sequence coverage in protein identification by matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS). Sample solution of tryptic peptides from proteins was mixed with the MNPs, and the MNPs were separated from the supernatant using a magnet. MALDI mass spectra obtained separately from the supernatant and the MNPs were distinctly different and complementary to each other. Combination of the two spectra led to a significantly increased sequence coverage.
Introduction
In proteomics research, matrix-assisted laser desorption/ ionization time-of-flight mass spectrometric (MALDI-TOF-MS) peptide mass mapping is commonly used for protein identification. A cellular protein is separated, by HPLC or two-dimensional electrophoresis for example, and hydrolyzed usually by trypsin. Analysis of the resulting peptides leads to identification of the protein. In MALDI-TOF-MS analysis, some of the peptides in the tryptic digest are suppressed by the more readily desorbed and ionized peptides. As a result, the peptide mass map and the protein sequence coverage is incomplete. This is not a problem for protein identification, because accurate mass information for only a few peptides is enough for a unique protein assignment. However, it is often necessary to analyze proteins present at low levels in a cell. In such cases, the mass spectrum may not provide enough information and increasing the number of peptide peaks detected becomes important for improved sequence coverage and definitive protein identification. 1 Moreover, the newly detected peptides might contain key information, such as post-translational modification, relevant to functional proteomics studies.
One approach to improve sequence coverage is to obtain mass spectrum in the negative ionization mode using matrix with added phosphoric acid as well as in the normal positive mode. For example, recently Sanaki, T. et al. achieved improved sequence coverage by combining positive and negative ionization mode data. Recently, nanoparticles have been used for various applications in peptide and protein analyses. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Generally, the applications involve either selection or enrichment of particular peptides via surface modification of nanoparticles or repeated digestion using enzyme bound to nanoparticles. Zhang et al. made funtionalized MALDI plate using 4-mercaptophenylboronic acid on gold nanoparticles for onplate selective enrichment of glycoproteins. 3 Kim et al. used polymer nanofilbers to immobilize trypsin for reuse. 4 Lee et al. used commercial magnetic beads with aminophenylboronic acid immobilized to enrich glycoproteins. 5 Yang et al. achieved high stability of enzymes by immobilizing on nanodiamond. 6 Kong et al. used carboxylated diamond nanoparticles to separate hydrophilic and hydrophobic proteins by affinity capture. 7 Jeng et al. immobilized enzyme to magnetic nanoparticles for easy separation from solution. 8 Kumarathasan et al. purified rat plasma proteins using commercially available weak cation-exchange magnetic beads and analyzed proteins bound to the beads discarding the supernatant.
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In this paper, we propose to use magnetic nanoparticles treated with phosphoric acid (MNP-PA) to obtain separate mass spectra from the supernatant and from the nanoparticles after mixing peptide solution with MNP-PA. Peptides are separated into two broad groups using magnetic nanoparticles, based on non-covalent interaction between the peptides and the nanoparticle surface, and both groups are mass spectrometrically analyzed for complementary results. The ironbased magnetic nanoparticles we used are easy to prepare, disperse and separate from solution using a magnet. MNP-PA can be used to obtain peptide peaks from tryptic digest of proteins that were not detected without the use of magnetic nanoparticles. Significant enhancement in sequence coverage was achieved from several model proteins.
Experimental Section
Materials. Trifluoroacetic acid (TFA), iron (III) chloride hexahydrate, iron (II) chloride tetra hydrate, ammonium hydroxide, ammonium bicarbonate, α-cyano-4-hydroxycinnamic acid (CHCA), β-casein, bovine serum albumin (BSA), hemoglobin, human fibrinogen, lysozyme, ovalbumin, poly-lysine and TPCK-treated trypsin were obtained from Sigma-Aldrich (St. Louis, MO, USA 10 Black particles produced showed a strong magnetic property. Dried magnetic nanoparticles aggregated to some extent were ground to fine powder with mortar and pestle. Before use, a portion of the Fe 3 O 4 nanoparticles was dispersed in 1% phosphoric acid in acetone at 40 mg/mL concentration and vortex-mixed for 30 min. Typically, 10 μL of the MNP-PA suspension was added to 50 μL of the tryptic digest, and the mixture was vortexmixed for 30 min. The mixture was centrifuged briefly to collect material on the wall of the tube. Then, while holding a magnet on the outer wall of the sample tube to collect the MNPs, the supernatant was transferred to another tube using a micropipette. MNPs remaining in the sample tube were washed several times with distilled water. This procedure separated the peptides into two groups, one group remaining in the supernatant and another bound to the MNPs (MNP-PA).
MALDI-TOF-MS Analysis. Matrix solution was prepared by dissolving CHCA in 50% ACN/50% distilled water containing 0.1% TFA at 10 mg/mL concentration. 1 μL of the matrix solution was mixed with 1 μL of the sample solution (supernatant or MNP-PA dispersed in 1 μL distilled water), and 1 μL of the mixture was loaded onto the MTP Anchor Chip var-384 plate. After drying under vacuum, MALDI mass spectra were obtained using Bruker AutoflexII MALDI time-of-flight mass spectrometer (Bruker Daltonics, Bremen, Germany). A total of 50 shots on the positive ion linear mode were averaged.
Results and Discussion
We tested the efficacy of the method using five proteins BSA, β-casein, hemoglobin, lysozyme, and ovalbumin. Figure  1 shows mass spectra from control BSA tryptic peptides without MNP-PA treatment (a), from supernatant after mixing with MNP-PA (b), and from MNP-PA (c). Mass spectrum from the supernatant in Figure 1(b) was generally similar to the control ( Fig. 1(a)) ; however, ionization efficiency was significantly enhanced. Good mass spectrum was obtained at lower laser power, and the S/N ratio was improved.
The signal enhancement led to observation of several new peaks not observed in Figure 1(a) . Figure 2 shows, in an expanded scale, the signal enhancement from several BSA tryptic peptides in the supernatant (Fig. 1(b) ). The peak at m/z 926 was enhanced about 3-fold in S/N. The peaks at m/z 1162, 1518, and 1566 were enhanced more than 10-fold; they were below the noise level in the control.
The advantage of using MNP-PA was more evident in the mass spectrum obtained from the MNP-PA portion ( Fig.  1(c) ). Signal intensity was somewhat decreased in the mass spectrum from the MNP-PA; however, noise was also suppressed facilitating detection of low intensity peaks. Peaks detected from the MNP-PA, but not observed from the control or the supernatant, are marked in Figure 1(c) . Figure  3 shows signal enhancement from several peptides. To test the role of PA in the MNP-PA, the BSA tryptic peptides were mixed with bare MNP without the PA treatment. Signal enhancement observed after MNP-PA treatment was not obtained without the PA treatment either from the supernatant or from the MNP (result not shown). Figure 4 shows the BSA sequence matched from the peptide mass maps. Only 14% was covered using the control mass spectrum ( Fig. 1(a) ). The coverage was increased almost 4-fold to 58% using peaks combined from Figure  1 (b) and 1(c). The amino acid residues covered only from peaks obtained from the MNP-PA are denoted in bold. The total number of residues in bold is 137, corresponding to about half of the number of residues covered by the combined peaks (Fig. 4(b) ). Moreover, the number of residues in bold exceeds the number of residues covered in Figure 1(a) . This observation alone demonstrates the advantage of using the MNP-PA system for improved sequence coverage. Sequence search results are summarized in Table 1 for BSA tryptic peptides showing S/N greater than 6. Similar results were obtained from other proteins. Increased sequence coverage for five proteins is summarized in Table 2 . The increase was not significant for a low molecular weight protein, lysozyme (from 72% to 93%). However, about 4-fold increase (from 14% to 58%) was obtained for a high molecular weight protein (BSA), where a large number of tryptic peptides could be suppressed and not observable in the control mass spectrum. MNP-PA treatment increases the S/N ratio and makes more peptides detectable thus increasing the sequence coverage.
The signal enhancement in the supernatant appeared to be due to removal of salt in the sample solution by the MNP-PA. This was tested by adding NaCl to the BSA peptides and proved by observing the signal enhancement after treating the sample with MNP-PA (result not shown). Most dramatic demonstration was obtained using human fibrinogen commercially available with high salt content to prevent aggregation of the proteins. Tryptic peptides from fibrinogen without any treatment were not detected at all (Fig. 5(a) ). After removal of salt using Zip-tip, mass spectrum in Figure  5 (b) was obtained leading to 5% sequence coverage. When the same tryptic peptides were treated with MNP-PA, mass spectra in Figure 5 (c) and 5(d) were obtained from the supernatant and MNP-PA, respectively. The sequence coverage from the supernatant and MNP-PA was 15% and 8%, respectively, resulting in 18% using combined peptide peaks. The signal enhancement in the MNP-PA was more intriguing. The physical state of the MNP-PA surface is not known. We suspect that the interaction between phosphoric acid and the nanoparticles is not covalent but electrostatic, considering the mild treatment of the nanoparticles with phosphoric acid. The positive charges on the peptide might interact again electrostatically with the negatively charged phosphate groups on the large surface area of the nanoparticles. Partial removal of salt might also occur similarly.
The charge interaction between positively charged peptides and MNP-PA was tested using poly-lysine (average MW, 1000 Da). A distribution was observed from both control ( Fig. 6(a) ) and the supernatant (Fig. 6(b) ) with a maximum intensity around 700 Da. The highest MW detected was about 1400 Da. On the other hand, a different distribution was observed from MNP-PA (Fig. 6(c) ) with a maximum intensity around 1100 Da and the highest MW detected around 3700 Da. Figure 6 (c) also shows that sodium and potassium adduct peaks were much smaller from MNP-PA than from control or the supernatant. Therefore, the poly-lysine ladder with 128 Da interval was evident from the MNP-PA spectrum.
This shift to the high MW region implies that peptides with more lysine residues and thus with higher positive charge are more strongly bound to MNP-PA and detected when the MNP-PA portion is subjected to MALDI analysis. This charge interaction might explain detection of new peaks from tryptic peptides in five proteins tested. Charge interaction might also explain the lack of salt adducts in Figure  6 (c). Na + and K + ions bound to the MNP-PA cannot participate in the adduct formation. Desalting effect suggested above ( Fig. 1(b) , Fig. 5(c) ) may also arise from binding of salts in the sample solution to MNP-PA.
Conclusions
Fe 3 O 4 magnetic nanoparticles treated with phosphoric acid were used to separate peptides in solution into two portions. Peptides remaining in the supernatant after mixing with the nanoparticles showed enhanced signal probably due to removal of salt by the phosphoric acid on the nanoparticles. Peptides undetected either from the control sample solution or from the supernatant were detected from the nanoparticles. Combination of peptides from the two portions leads to enhanced sequence coverage in the protein analysis by MALDI-TOF-MS. 
